Groups work to engage young voters in democracy as election processes come under scrutiny
Murder suspect arrested after 9-hour standoff with police in Compton
Trump launches a new business venture during his campaign: $100,000 watches
The UN's nuclear chief says the world needs to pursue dialogue with North Korea over nuclear weapons
'Grave breach of the public's trust': US attorney on New York mayor's indictment
What is the 2006 UN resolution that some hope could help to end the Israel-Hezbollah conflict?
The US is giving Ukraine billions more in weapons. Here's how they will help
How to make sure your generator doesn't kill you
White Sox stay at 120 losses as Flexen shines in 7-0 victory over Angels
Memphis man gets life sentence for killing rapper Young Dolph
Melania Trump calls her husband's survival of assassination attempts 'miracles'
(Reuters) - Concentra Group set the pricing of its U.S. initial public offering (IPO) at a valuation of $2.97 billion, the U.S. healthcare firm said on Wednesday.
The company, which is a unit of Select Medical , priced its IPO at $23.5 apiece, close to the lower end of its targeted range of $23 to $26. It aims to raise around $528.8 million.
Concentra, founded in 1979, is now the largest provider of occupational health services in the United States by number of locations, according to its IPO prospectus.
Earlier this year, Select Medical announced its plan to pursue the separation of Concentra and to create two independent and publicly traded companies.
Concentra is expected to begin trading on the New York Stock Exchange on July 25 under the ticker symbol "CON".
(Reporting by Shivani Tanna in Bengaluru; Editing by Sherry Jacob-Phillips and Eileen Soreng)
